The following highlights spotlight the latest research in rheumatology, featuring studies presented at this year’s annual European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...
The School of Infection & Immunity's Dr Eve Smith recently received the prestigious EULAR Abstract Award – FOREUM: Clinical Science at this year’s EULAR 2025 Congress. The world’s largest rheumatology ...
We read with great interest the new EULAR guidelines1 for the management of systemic lupus erythematosus (SLE), and we appreciate the care taken in synthesising the newest research to advance best ...
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License. THE European Alliance of Associations for Rheumatology (EULAR) 2024 Congress took place ...
We appreciate the comments by Damoiseaux and van Beers1 in response to the publication of the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) ...
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback